Concomitant granule cell neuronopathy in patients with natalizumab-associated PML

MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS

(2015) Mike P Wattjes et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

JC virus granule cell neuronopathy: A cause of infectious cerebellar degeneration

(2015) Carole Henry et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—establishing disease prognosis and monitoring patients

(2015)   Nature Reviews Neurology

Heterogeneous imaging characteristics of JC virus granule cell neuronopathy (GCN): a case series and review of the literature

(2014) Martijn T. Wijburg et al.   JOURNAL OF NEUROLOGY

MRI pattern in asymptomatic natalizumab-associated PML

(2014) Mike P Wattjes et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene

(2014) S. P. Agnihotri et al.   NEUROLOGY

JC Polyomavirus Granule Cell Neuronopathy in a Patient Treated With Rituximab

(2014) Louis Dang et al.   JAMA Neurology

PML diagnostic criteria: Consensus statement from the AAN Neuroinfectious Disease Section

(2013) J. R. Berger et al.   NEUROLOGY

Natalizumab

(2012) Richard Rudick et al.   JAMA Neurology

Visual assessment of posterior atrophy development of a MRI rating scale

(2011) Esther L. G. E. Koedam et al.   EUROPEAN RADIOLOGY

Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis

(2010) Chen S Tan et al.   LANCET NEUROLOGY

What lies beneath the tent? JC-virus cerebellar granule cell neuronopathy complicating sarcoidosis

(2009) Ron Granot et al.   JOURNAL OF CLINICAL NEUROSCIENCE